speb/financial-data huggingface dataset:
ACA cash_flow (annual, 2025-12-31) — Changes In Cash: 27300000.00
ACA cash_flow (quarterly, 2025-12-31) — Changes In Cash: -5400000.00
ACA balance_sheet (annual, 2025-12-31) — Common Stock: 500000.00
ACA balance_sheet (quarterly, 2025-12-31) — Common Stock: 500000.00
ACA cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -10000000.00
ACA cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -2500000.00
ACA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2641400000.00
ACA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2641400000.00
ACA cash_flow (annual, 2025-12-31) — Common Stock Payments: -12900000.00
ACA cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -500000.00
ACA balance_sheet (annual, 2025-12-31) — Construction In Progress: 136500000.00
ACA balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 136500000.00
ACA income_statement (annual, 2025-12-31) — Cost Of Revenue: 2236200000.00
ACA income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 552900000.00
ACA balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 178800000.00
ACA balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 178800000.00
ACA balance_sheet (annual, 2025-12-31) — Current Assets: 1106500000.00
ACA balance_sheet (quarterly, 2025-12-31) — Current Assets: 1106500000.00
ACA balance_sheet (annual, 2025-12-31) — Current Debt: 8500000.00
ACA balance_sheet (quarterly, 2025-12-31) — Current Debt: 8500000.00
ACA balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 8500000.00
ACA balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 8500000.00
ACA balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 57000000.00
ACA balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 57000000.00
ACA balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 57000000.00
ACA balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 57000000.00
ACA balance_sheet (annual, 2025-12-31) — Current Liabilities: 503600000.00
ACA balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 503600000.00
ACA cash_flow (annual, 2025-12-31) — Deferred Income Tax: 26000000.00
ACA cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 4500000.00
ACA cash_flow (annual, 2025-12-31) — Deferred Tax: 26000000.00
ACA cash_flow (quarterly, 2025-12-31) — Deferred Tax: 4500000.00
ACA cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 223000000.00
ACA cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 57100000.00
ACA income_statement (annual, 2025-12-31) — Diluted Average Shares: 49000000.00
ACA income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 49100000.00
ACA income_statement (annual, 2025-12-31) — Diluted EPS: 4.24
ACA income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.06
ACA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 208000000.00
ACA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 51700000.00
ACA income_statement (annual, 2025-12-31) — EBIT: 350100000.00
ACA income_statement (quarterly, 2025-12-31) — EBIT: 80100000.00
ACA income_statement (annual, 2025-12-31) — EBITDA: 573100000.00
ACA income_statement (quarterly, 2025-12-31) — EBITDA: 137200000.00
ACA cash_flow (annual, 2025-12-31) — End Cash Position: 214600000.00
ACA cash_flow (quarterly, 2025-12-31) — End Cash Position: 214600000.00
ACA cash_flow (annual, 2025-12-31) — Financing Cash Flow: -192400000.00
ACA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -64000000.00
ACA balance_sheet (annual, 2025-12-31) — Finished Goods: 213400000.00
ACA balance_sheet (quarterly, 2025-12-31) — Finished Goods: 213400000.00
ACA cash_flow (annual, 2025-12-31) — Free Cash Flow: 175500000.00
ACA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 55800000.00
ACA balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -16400000.00
ACA balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -16400000.00
ACA balance_sheet (annual, 2025-12-31) — Goodwill: 1348900000.00
ACA balance_sheet (quarterly, 2025-12-31) — Goodwill: 1348900000.00
ACA balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 1659700000.00
ACA balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 1659700000.00
ACA balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 427300000.00
ACA balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 427300000.00
ACA balance_sheet (annual, 2025-12-31) — Gross PPE: 3184600000.00
ACA balance_sheet (quarterly, 2025-12-31) — Gross PPE: 3184600000.00
ACA income_statement (annual, 2025-12-31) — Gross Profit: 647200000.00
ACA income_statement (quarterly, 2025-12-31) — Gross Profit: 163800000.00
ACA income_statement (annual, 2025-12-31) — Interest Expense: 108800000.00
ACA income_statement (quarterly, 2025-12-31) — Interest Expense: 24900000.00
ACA income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 108800000.00
ACA income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 24900000.00
ACA income_statement (annual, 2025-12-31) — Interest Income: 6600000.00
ACA income_statement (quarterly, 2025-12-31) — Interest Income: 1700000.00
ACA income_statement (annual, 2025-12-31) — Interest Income Non Operating: 6600000.00
ACA income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1700000.00
ACA cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 103100000.00
ACA balance_sheet (annual, 2025-12-31) — Inventory: 424200000.00
ACA balance_sheet (quarterly, 2025-12-31) — Inventory: 424200000.00
ACA balance_sheet (annual, 2025-12-31) — Invested Capital: 4164200000.00
ACA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 4164200000.00
ACA cash_flow (annual, 2025-12-31) — Investing Cash Flow: -121400000.00
ACA cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -61400000.00
ACA cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
ACA cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
ACA balance_sheet (annual, 2025-12-31) — Land And Improvements: 197000000.00
ACA balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 197000000.00
ACA balance_sheet (annual, 2025-12-31) — Long Term Debt: 1514300000.00
ACA balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1514300000.00
ACA balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1514300000.00
ACA balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1514300000.00
ACA cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
ACA cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
ACA cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -168700000.00
ACA cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -61000000.00
ACA balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1292900000.00
ACA balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1292900000.00
ACA cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 17600000.00
ACA cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
ACA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -12900000.00
ACA cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -500000.00
ACA balance_sheet (annual, 2025-12-31) — Net Debt: 1308200000.00
ACA balance_sheet (quarterly, 2025-12-31) — Net Debt: 1308200000.00
ACA income_statement (annual, 2025-12-31) — Net Income: 208400000.00
ACA income_statement (quarterly, 2025-12-31) — Net Income: 52100000.00
ACA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 208000000.00
ACA income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 51700000.00
ACA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 208400000.00
ACA income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 52100000.00
ACA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 208400000.00
ACA income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 52100000.00
ACA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 208400000.00
ACA income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 52100000.00
ACA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 208400000.00
ACA cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 52100000.00
ACA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 208400000.00
ACA income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 52100000.00
ACA income_statement (annual, 2025-12-31) — Net Interest Income: -102200000.00
ACA income_statement (quarterly, 2025-12-31) — Net Interest Income: -23200000.00
ACA cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -168700000.00
ACA cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -61000000.00
ACA cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -168700000.00
ACA cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -61000000.00
ACA income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -102200000.00
ACA income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -23200000.00
ACA cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -800000.00
ACA cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
ACA cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 26600000.00
ACA cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 2800000.00
ACA balance_sheet (annual, 2025-12-31) — Net PPE: 2097800000.00
ACA balance_sheet (quarterly, 2025-12-31) — Net PPE: 2097800000.00
ACA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 981700000.00
ACA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 981700000.00
ACA balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 7200000.00
ACA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 7200000.00
ACA balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 230800000.00
ACA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 230800000.00
ACA balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 7200000.00
ACA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 7200000.00
ACA balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 230800000.00
ACA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 230800000.00
ACA income_statement (annual, 2025-12-31) — Normalized EBITDA: 573100000.00
ACA income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 137200000.00
ACA income_statement (annual, 2025-12-31) — Normalized Income: 208400000.00
ACA income_statement (quarterly, 2025-12-31) — Normalized Income: 52100000.00
ACA cash_flow (annual, 2025-12-31) — Operating Cash Flow: 341100000.00
ACA cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 120000000.00
ACA cash_flow (annual, 2025-12-31) — Operating Gains Losses: -3400000.00
ACA cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 7000000.00
ACA income_statement (annual, 2025-12-31) — Operating Income: 341900000.00
ACA income_statement (quarterly, 2025-12-31) — Operating Income: 79000000.00
ACA income_statement (annual, 2025-12-31) — Operating Revenue: 2883400000.00
ACA income_statement (quarterly, 2025-12-31) — Operating Revenue: 716700000.00
ACA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 49045025.00
ACA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 49045025.00
ACA balance_sheet (annual, 2025-12-31) — Other Current Assets: 50000000.00
ACA balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 50000000.00
ACA balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -16400000.00
ACA balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -16400000.00
ACA income_statement (annual, 2025-12-31) — Other Income Expense: 1600000.00
ACA income_statement (quarterly, 2025-12-31) — Other Income Expense: -600000.00
ACA balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 310800000.00
ACA balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 310800000.00
ACA cash_flow (annual, 2025-12-31) — Other Non Cash Items: 13600000.00
ACA cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 14000000.00
ACA balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 114000000.00
ACA balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 114000000.00
ACA balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 95100000.00
ACA balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 95100000.00
ACA income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 1600000.00
ACA income_statement (annual, 2025-12-31) — Other Operating Expenses: -1800000.00
ACA income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 6600000.00
ACA income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 400000.00
ACA balance_sheet (annual, 2025-12-31) — Payables: 259300000.00
ACA balance_sheet (quarterly, 2025-12-31) — Payables: 259300000.00
ACA balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 438100000.00
ACA balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 438100000.00
ACA income_statement (annual, 2025-12-31) — Pretax Income: 241300000.00
ACA income_statement (quarterly, 2025-12-31) — Pretax Income: 55200000.00
ACA balance_sheet (annual, 2025-12-31) — Properties: 1114700000.00
ACA balance_sheet (quarterly, 2025-12-31) — Properties: 1114700000.00
ACA balance_sheet (annual, 2025-12-31) — Raw Materials: 173700000.00
ACA balance_sheet (quarterly, 2025-12-31) — Raw Materials: 173700000.00
ACA balance_sheet (annual, 2025-12-31) — Receivables: 417700000.00
ACA balance_sheet (quarterly, 2025-12-31) — Receivables: 417700000.00
ACA income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 2236200000.00
ACA income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 552900000.00
ACA income_statement (annual, 2025-12-31) — Reconciled Depreciation: 223000000.00
ACA income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 57100000.00
ACA cash_flow (annual, 2025-12-31) — Repayment Of Debt: -168700000.00
ACA cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -61000000.00
ACA cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -12900000.00
ACA cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -500000.00
ACA balance_sheet (annual, 2025-12-31) — Retained Earnings: 947300000.00
ACA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 947300000.00
ACA cash_flow (annual, 2025-12-31) — Sale Of Business: 17600000.00
ACA cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
ACA income_statement (annual, 2025-12-31) — Selling General And Administration: 307100000.00
ACA income_statement (quarterly, 2025-12-31) — Selling General And Administration: 78200000.00
ACA balance_sheet (annual, 2025-12-31) — Share Issued: 49045025.00
ACA balance_sheet (quarterly, 2025-12-31) — Share Issued: 49045025.00
ACA cash_flow (annual, 2025-12-31) — Stock Based Compensation: 26400000.00
ACA cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 6600000.00
ACA balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2641400000.00
ACA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2641400000.00
ACA balance_sheet (annual, 2025-12-31) — Tangible Book Value: 981700000.00
ACA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 981700000.00
ACA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ACA income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ACA income_statement (annual, 2025-12-31) — Tax Provision: 32900000.00
ACA income_statement (quarterly, 2025-12-31) — Tax Provision: 3100000.00
ACA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.14
ACA income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.06
ACA balance_sheet (annual, 2025-12-31) — Total Assets: 4985200000.00
ACA balance_sheet (quarterly, 2025-12-31) — Total Assets: 4985200000.00
ACA balance_sheet (annual, 2025-12-31) — Total Capitalization: 4155700000.00
ACA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 4155700000.00
ACA balance_sheet (annual, 2025-12-31) — Total Debt: 1522800000.00
ACA balance_sheet (quarterly, 2025-12-31) — Total Debt: 1522800000.00
ACA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2641400000.00
ACA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2641400000.00
ACA income_statement (annual, 2025-12-31) — Total Expenses: 2541500000.00
ACA income_statement (quarterly, 2025-12-31) — Total Expenses: 637700000.00
ACA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2343800000.00
ACA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2343800000.00
ACA balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 3878700000.00
ACA balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 3878700000.00
ACA balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1840200000.00
ACA balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1840200000.00
ACA income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 341900000.00
ACA income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 79000000.00
ACA balance_sheet (annual, 2025-12-31) — Work In Process: 37100000.00
ACA balance_sheet (quarterly, 2025-12-31) — Work In Process: 37100000.00
ACA balance_sheet (annual, 2025-12-31) — Working Capital: 602900000.00
ACA balance_sheet (quarterly, 2025-12-31) — Working Capital: 602900000.00
ACA income_statement (quarterly, 2026-03-31) — +Operating Expense: 73800000.00
ACA income_statement (quarterly, 2026-03-31) — +Total Revenue: 571700000.00
ACA balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 229500000.00
ACA balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 413900000.00
ACA balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -994900000.00
ACA balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1716500000.00
ACA balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 164100000.00
ACA income_statement (quarterly, 2026-03-31) — Basic Average Shares: 49000000.00
ACA income_statement (quarterly, 2026-03-31) — Basic EPS: 0.77
ACA cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 214600000.00
ACA balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 350500000.00
ACA cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -43500000.00
ACA cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -43500000.00
ACA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 500000.00
ACA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 153200000.00
ACA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 153200000.00
ACA cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -2400000.00
ACA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -35000000.00
ACA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -96900000.00
ACA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 58100000.00
ACA cash_flow (quarterly, 2026-03-31) — Cash From Discontinued Investing Activities: -1400000.00
ACA cash_flow (quarterly, 2026-03-31) — Cash From Discontinued Operating Activities: 13800000.00
ACA cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 15300000.00
ACA cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -34900000.00
ACA cash_flow (quarterly, 2026-03-31) — Change In Inventory: -14600000.00
ACA cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -2400000.00
ACA cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 1400000.00
ACA cash_flow (quarterly, 2026-03-31) — Change In Payable: 15300000.00
ACA cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -19600000.00
ACA cash_flow (quarterly, 2026-03-31) — Change In Receivables: 0.00
ACA cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -35200000.00
ACA cash_flow (quarterly, 2026-03-31) — Changes In Cash: -61400000.00
ACA balance_sheet (quarterly, 2026-03-31) — Common Stock: 500000.00
ACA cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -2400000.00
ACA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2652700000.00
ACA cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -30200000.00
ACA balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 155100000.00
ACA income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 450800000.00
ACA balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 141700000.00
ACA balance_sheet (quarterly, 2026-03-31) — Current Assets: 1133400000.00
ACA balance_sheet (quarterly, 2026-03-31) — Current Debt: 8000000.00
ACA balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 8000000.00
ACA balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 27300000.00
ACA balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 27300000.00
ACA balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 489600000.00
ACA cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 9500000.00
ACA cash_flow (quarterly, 2026-03-31) — Deferred Tax: 9500000.00
ACA cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 53500000.00
ACA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 49200000.00
ACA income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.77
ACA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 37700000.00
ACA income_statement (quarterly, 2026-03-31) — EBIT: 48600000.00
ACA income_statement (quarterly, 2026-03-31) — EBITDA: 102100000.00
ACA cash_flow (quarterly, 2026-03-31) — End Cash Position: 153200000.00
ACA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -35000000.00
ACA balance_sheet (quarterly, 2026-03-31) — Finished Goods: 203600000.00
ACA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 28400000.00
ACA balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -16800000.00
ACA balance_sheet (quarterly, 2026-03-31) — Goodwill: 1342700000.00
ACA balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1647200000.00
ACA balance_sheet (quarterly, 2026-03-31) — Gross PPE: 3096800000.00
ACA income_statement (quarterly, 2026-03-31) — Gross Profit: 120900000.00
ACA income_statement (quarterly, 2026-03-31) — Interest Expense: 24000000.00
ACA income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 24000000.00
ACA income_statement (quarterly, 2026-03-31) — Interest Income: 1600000.00
ACA income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1600000.00
ACA balance_sheet (quarterly, 2026-03-31) — Inventory: 350000000.00
ACA balance_sheet (quarterly, 2026-03-31) — Invested Capital: 4173800000.00
ACA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -98300000.00
ACA balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 194700000.00
ACA balance_sheet (quarterly, 2026-03-31) — Liabilities Heldfor Sale Non Current: 0.00
ACA balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1513100000.00
ACA balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1513100000.00
ACA cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -2400000.00
ACA balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 1241500000.00
ACA cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -60000000.00
ACA cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -30200000.00
ACA balance_sheet (quarterly, 2026-03-31) — Net Debt: 1367900000.00
ACA income_statement (quarterly, 2026-03-31) — Net Income: 37800000.00
ACA income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 37700000.00
ACA income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 23300000.00
ACA income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: 14500000.00
ACA income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 37800000.00
ACA income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 23300000.00
ACA cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 23300000.00
ACA income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 37800000.00
ACA income_statement (quarterly, 2026-03-31) — Net Interest Income: -22400000.00
ACA cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -2400000.00
ACA cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -2400000.00
ACA income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -22400000.00
ACA cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 6600000.00
ACA balance_sheet (quarterly, 2026-03-31) — Net PPE: 2101900000.00
ACA balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1005500000.00
ACA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 7200000.00
ACA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 254000000.00
ACA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 7200000.00
ACA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 254000000.00
ACA income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 102100000.00
ACA income_statement (quarterly, 2026-03-31) — Normalized Income: 23300000.00
ACA cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 71900000.00
ACA cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -2000000.00
ACA income_statement (quarterly, 2026-03-31) — Operating Income: 47100000.00
ACA income_statement (quarterly, 2026-03-31) — Operating Revenue: 571700000.00
ACA balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 49098579.00
ACA balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 52200000.00
ACA balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 83100000.00
ACA balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -16800000.00
ACA income_statement (quarterly, 2026-03-31) — Other Income Expense: -100000.00
ACA balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 304500000.00
ACA cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 2700000.00
ACA balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 112600000.00
ACA balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 92900000.00
ACA income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -100000.00
ACA income_statement (quarterly, 2026-03-31) — Other Operating Expenses: -2000000.00
ACA income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 100000.00
ACA balance_sheet (quarterly, 2026-03-31) — Payables: 229500000.00
ACA balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 371200000.00
ACA income_statement (quarterly, 2026-03-31) — Pretax Income: 24600000.00
ACA balance_sheet (quarterly, 2026-03-31) — Properties: 1155000000.00
ACA balance_sheet (quarterly, 2026-03-31) — Raw Materials: 129700000.00
ACA balance_sheet (quarterly, 2026-03-31) — Receivables: 413900000.00
ACA income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 450800000.00
ACA income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 53500000.00
ACA cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -2400000.00
ACA cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -30200000.00
ACA balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 982700000.00
ACA income_statement (quarterly, 2026-03-31) — Selling General And Administration: 75800000.00
ACA balance_sheet (quarterly, 2026-03-31) — Share Issued: 49398579.00
ACA cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 6300000.00
ACA balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2652700000.00
ACA balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1005500000.00
ACA income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ACA income_statement (quarterly, 2026-03-31) — Tax Provision: 1300000.00
ACA income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.05
ACA balance_sheet (quarterly, 2026-03-31) — Total Assets: 5002300000.00
ACA balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 4165800000.00
ACA balance_sheet (quarterly, 2026-03-31) — Total Debt: 1521100000.00
ACA balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2652700000.00
ACA income_statement (quarterly, 2026-03-31) — Total Expenses: 524600000.00
ACA balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2349600000.00
ACA balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3868900000.00
ACA balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1860000000.00
ACA income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 47100000.00
ACA balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 300000.00
ACA balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 30200000.00
ACA balance_sheet (quarterly, 2026-03-31) — Work In Process: 16700000.00
ACA balance_sheet (quarterly, 2026-03-31) — Working Capital: 643800000.00
ACA.PA cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 1369000000.00
ACA.PA cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 1369000000.00
ACA.PA cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -100000000.00
ACA.PA balance_sheet (annual, 2021-12-31) — Other Payable: 37258000000.00
ACA.PA income_statement (annual, 2022-12-31) — +Operating Expense: 13260000000.00
ACA.PA income_statement (annual, 2022-12-31) — +Total Revenue: 20646000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Accounts Payable: 35862000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -6437000000.00
ACA.PA income_statement (annual, 2022-12-31) — Amortization: 389000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 296066000000.00
ACA.PA income_statement (annual, 2022-12-31) — Basic Average Shares: 2989007006.00
ACA.PA income_statement (annual, 2022-12-31) — Basic EPS: 1.64
ACA.PA cash_flow (annual, 2022-12-31) — Beginning Cash Position: 159678000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Capital Expenditure: -1042000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Capital Stock: 29603000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 654924000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 778874000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -3226000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Cash Financial: 1580000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -1878000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Change In Working Capital: -1878000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Changes In Cash: -2974000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Common Stock: 29603000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -3226000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Common Stock Equity: 66519000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Depreciation: 1104000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1104000000.00
ACA.PA income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 1105000000.00
ACA.PA income_statement (annual, 2022-12-31) — Depreciation Income Statement: 716000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 149805000000.00
ACA.PA income_statement (annual, 2022-12-31) — Diluted Average Shares: 2989007006.00
ACA.PA income_statement (annual, 2022-12-31) — Diluted EPS: 1.64
ACA.PA income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 4894000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 679000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -1273000000.00
ACA.PA cash_flow (annual, 2022-12-31) — End Cash Position: 155431000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 219490000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Financing Cash Flow: 598000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Free Cash Flow: 421000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -14000000.00
ACA.PA income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -1025000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Goodwill: 15682000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 18776000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Gross PPE: 12457000000.00
ACA.PA income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: -1000000.00
ACA.PA income_statement (annual, 2022-12-31) — Insurance And Claims: -799000000.00
ACA.PA income_statement (annual, 2022-12-31) — Interest Expense: 16966000000.00
ACA.PA income_statement (annual, 2022-12-31) — Interest Income: 30013000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Invested Capital: 304604000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Investing Cash Flow: -5035000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Investment Properties: 11974000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 650881000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Investments And Advances: 655181000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 239899000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 4300000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Minority Interest: 8961000000.00
ACA.PA income_statement (annual, 2022-12-31) — Minority Interests: -880000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -3606000000.00
ACA.PA income_statement (annual, 2022-12-31) — Net Income: 5306000000.00
ACA.PA income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 4894000000.00
ACA.PA income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 6065000000.00
ACA.PA income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 121000000.00
ACA.PA income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 5306000000.00
ACA.PA income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 5185000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 7871000000.00
ACA.PA income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 6186000000.00
ACA.PA income_statement (annual, 2022-12-31) — Net Interest Income: 13047000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 4678000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 4678000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 3824000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -387000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Net PPE: 6020000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1042000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 47743000000.00
ACA.PA income_statement (annual, 2022-12-31) — Normalized Income: 5194868300.00
ACA.PA cash_flow (annual, 2022-12-31) — Operating Cash Flow: 1463000000.00
ACA.PA income_statement (annual, 2022-12-31) — Operating Revenue: 20646000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 3023566136.00
ACA.PA balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 3094000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Other Non Cash Items: 2294000000.00
ACA.PA income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -6000000.00
ACA.PA income_statement (annual, 2022-12-31) — Other Operating Expenses: 5055000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Other Payable: 35862000000.00
ACA.PA income_statement (annual, 2022-12-31) — Other Special Charges: 17000000.00
ACA.PA income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 412000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Payables: 37438000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1303000000.00
ACA.PA income_statement (annual, 2022-12-31) — Pretax Income: 7871000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: -6882000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Receivables: 104450000000.00
ACA.PA income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1104000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Retained Earnings: 5306000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Share Issued: 3042560716.00
ACA.PA income_statement (annual, 2022-12-31) — Special Income Charges: -13000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Stockholders Equity: 66519000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Tangible Book Value: 47743000000.00
ACA.PA income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -3131700.00
ACA.PA income_statement (annual, 2022-12-31) — Tax Provision: 1806000000.00
ACA.PA income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.24
ACA.PA balance_sheet (annual, 2022-12-31) — Taxes Receivable: 1883000000.00
ACA.PA cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -1213000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Total Assets: 2138086000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Total Capitalization: 304604000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Total Debt: 239899000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 75480000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 2062606000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Total Tax Payable: 1576000000.00
ACA.PA income_statement (annual, 2022-12-31) — Total Unusual Items: -13000000.00
ACA.PA income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -13000000.00
ACA.PA balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 18994580.00
ACA.PA income_statement (annual, 2022-12-31) — Write Off: -3000000.00
ACA.PA income_statement (annual, 2023-12-31) — +Operating Expense: 14145000000.00
ACA.PA income_statement (annual, 2023-12-31) — +Total Revenue: 23454000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Accounts Payable: 39901000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -7406000000.00
ACA.PA income_statement (annual, 2023-12-31) — Amortization: 455000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 295287000000.00
ACA.PA income_statement (annual, 2023-12-31) — Basic Average Shares: 3031055333.00
ACA.PA income_statement (annual, 2023-12-31) — Basic EPS: 1.94
ACA.PA cash_flow (annual, 2023-12-31) — Beginning Cash Position: 155431000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Capital Expenditure: -885000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Capital Stock: 30907000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 598933000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 759166000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -3463000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Cash Financial: 1519000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -61147000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Change In Working Capital: -61147000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Changes In Cash: -10114000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Common Stock: 30907000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -3463000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Common Stock Equity: 71086000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Depreciation: 1151000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1151000000.00
ACA.PA income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 1155000000.00
ACA.PA income_statement (annual, 2023-12-31) — Depreciation Income Statement: 700000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 119429000000.00
ACA.PA income_statement (annual, 2023-12-31) — Diluted Average Shares: 3031055333.00
ACA.PA income_statement (annual, 2023-12-31) — Diluted EPS: 1.94
ACA.PA income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 5890000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 618000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -2735000000.00
ACA.PA cash_flow (annual, 2023-12-31) — End Cash Position: 142584000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 269608000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Financing Cash Flow: 16546000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Free Cash Flow: -37397000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -85000000.00
ACA.PA income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -866000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Goodwill: 15929000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 19071000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Gross PPE: 15991000000.00
ACA.PA income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: -3000000.00
ACA.PA income_statement (annual, 2023-12-31) — Insurance And Claims: -821000000.00
ACA.PA income_statement (annual, 2023-12-31) — Interest Expense: 44877000000.00
ACA.PA income_statement (annual, 2023-12-31) — Interest Income: 59119000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Invested Capital: 349604000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Investing Cash Flow: 9852000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Investment Properties: 10824000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 687511000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Investments And Advances: 690110000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 280246000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 2599000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Minority Interest: 8833000000.00
ACA.PA income_statement (annual, 2023-12-31) — Minority Interests: -995000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 10737000000.00
ACA.PA income_statement (annual, 2023-12-31) — Net Income: 6348000000.00
ACA.PA income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 5890000000.00
ACA.PA income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 7346000000.00
ACA.PA income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -3000000.00
ACA.PA income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 6348000000.00
ACA.PA income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 6351000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 9547000000.00
ACA.PA income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 7343000000.00
ACA.PA income_statement (annual, 2023-12-31) — Net Interest Income: 14242000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 20010000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 20010000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 20009000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Net PPE: 8586000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -885000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 52015000000.00
ACA.PA income_statement (annual, 2023-12-31) — Normalized Income: 6097479500.00
ACA.PA cash_flow (annual, 2023-12-31) — Operating Cash Flow: -36512000000.00
ACA.PA income_statement (annual, 2023-12-31) — Operating Revenue: 23454000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 3029178810.00
ACA.PA cash_flow (annual, 2023-12-31) — Other Cash Adjustment Outside Changein Cash: 2000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 3142000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Other Non Cash Items: 5202000000.00
ACA.PA income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -15000000.00
ACA.PA income_statement (annual, 2023-12-31) — Other Operating Expenses: 5131000000.00
ACA.PA income_statement (annual, 2023-12-31) — Other Special Charges: -304000000.00
ACA.PA income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 458000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Payables: 41965000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1428000000.00
ACA.PA income_statement (annual, 2023-12-31) — Pretax Income: 9546000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 9659000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Receivables: 96194000000.00
ACA.PA income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1151000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Retained Earnings: 6348000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Share Issued: 3052737991.00
ACA.PA income_statement (annual, 2023-12-31) — Special Income Charges: 329000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Stockholders Equity: 71086000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Tangible Book Value: 52015000000.00
ACA.PA income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 77479500.00
ACA.PA income_statement (annual, 2023-12-31) — Tax Provision: 2200000000.00
ACA.PA income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.24
ACA.PA balance_sheet (annual, 2023-12-31) — Taxes Receivable: 2521000000.00
ACA.PA cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -1260000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Total Assets: 2189398000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Total Capitalization: 349604000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Total Debt: 280246000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 79919000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 2109479000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Total Tax Payable: 2064000000.00
ACA.PA income_statement (annual, 2023-12-31) — Total Unusual Items: 329000000.00
ACA.PA income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 329000000.00
ACA.PA balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 23559181.00
ACA.PA income_statement (annual, 2023-12-31) — Write Off: -20000000.00
ACA.PA income_statement (quarterly, 2024-09-30) — Basic Average Shares: 3031000000.00
ACA.PA income_statement (quarterly, 2024-09-30) — Basic EPS: 0.50
ACA.PA income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 3031000000.00
ACA.PA income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.50
ACA.PA income_statement (annual, 2024-12-31) — +Operating Expense: 14899000000.00
ACA.PA income_statement (quarterly, 2024-12-31) — +Operating Expense: 3921000000.00
ACA.PA income_statement (annual, 2024-12-31) — +Total Revenue: 25328000000.00
ACA.PA income_statement (quarterly, 2024-12-31) — +Total Revenue: 5234000000.00